Skip to main content
. Author manuscript; available in PMC: 2013 Jun 26.
Published in final edited form as: Curr Drug Targets. 2012 Aug;13(9):1121–1130. doi: 10.2174/138945012802002410

Table 1.

Antibacterial and antiendotoxic activities of the peptides and their N-acyl derived Lipopeptides

Compound Sequence1 MIC (μg/mL) of compound on the indicated bacterial strain
Ec Ec-2 Pa Pa-2 Ab Sm Bb Ba Sa
P2-15 F W R I R I R R -NH2 8 8 32 16 128 64 2 64 32
 LP3-55 octanoil-P2-15 32 16 64 64 64 256 8 8 16
 LP3-56 2-etilhexanoil-P2-15 16 8 32 64 64 128 8 8 16
 LP3-57 2,2-dimetilbutanoil-P2-15 8 8 32 8 64 128 4 8 8
 LP3-58 6-metiloctanoil-P2-15 32 16 64 256 64 256 16 8 64
 LP3-79 diciclohexilacetil-P2-15 32 64 256 64 256 >256 8 8 32

P2-27 F W R R F W R R -NH2 16 64 64 32 128 256 4 16 16
 LP3-60 octanoil-P2-27 64 128 128 128 256 256 8 8 128
 LP3-63 6-metiloctanoil-P2-27 64 64 256 128 256 128 8 16 16

P2-29 F W R I W R W R -NH2 16 16 32 8 32 128 4 16 8

P2-33 P F W R I R I R R -NH2 16 64 64 32 128 256 4 16 16
 LP3-53 octanoil-P2-33 64 128 128 128 256 256 8 8 128
1

Parent peptides and their N-acyl derivatives were synthesized with an amidated C-terminus

2

Minimum inhibitory concentration of the compound determined by a microbroth-based assay in Mueller-Hinton medium. Abbreviations: Ec, Escherichia coli ATCC 25922; Ec-2; Escherichia coli DC2; Pa, Pseudomonas aeruginosa 4158-02 CUN; Pa-2, Pseudomonas aeruginosa ATCC 27853; Ab, Acinetobacter baumannii ATCC 19606; Sm, Stenotrophomonas maltophilia 3998-00 CUN; Bb, Bordetella bronchiseptica 11844-99 CUN; Ba, Brucella abortus 9,49 perA; Sa, Staphylococcus aureus ATCC 25923; MRSA, Staphylococcus aureus ATCC 43300 (MRSA)

3

novobiocin enhancing activity of peptides on Pseudomonas aeruginosa Ps4 expressed as Fractional Inhibitory Concentration (FIC) index. FIC index was calculated according to the following formula: [(A) /MICA] + [(P) /MICP]= FICA + FICP = FIC index, where MICA and MICP are the MICs of the antibiotic and peptide determined separately, and (A) and (P) are the MICs of the antibiotic and peptide when determined in combination

4

number on the left: percentage of killing by the compound (MTT test; 4 h of treatment) when the peptide was added at 10 times its MIC on a biofilm of Pseudomonas aeruginosa PAO1; number on the right: percentage of biofilm removal determined by crystal violet staining under the same conditions of the killing assay. Values of standard deviation were always below 11%. n.d. not determined

5

survival of CD-1 mice after 7 days of being inoculated intraperitoneally (i.p) with 0.3 μg of lipopolysaccharide from Pseudomonas aeruginosa PAO1 followed 1 min later by the compound (150 μg, i.p.); galactosamine (18 mg) was co-inoculated with the lipopolysaccharide to sensitize the animals to endotoxin. −, +, ++, +++ denotes the level of protection (null, low, intermediate, high, respectively) afforded by the compound with respect to a control group of animals receiving no treatment